Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisapride for idiopathic gastroparesis exacerbations
NCT01281540Phase 4Terminated
- Sponsor
- Johnson & Johnson
- Start
- May 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cisapride in idiopathic gastroparesis (IG), sponsored by Johnson & Johnson. Started May 2003; status: terminated.
02
Drugs
cisapride
03
Conditions
idiopathic gastroparesis (IG)
Beyond the preview
Go deeper on NCT01281540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281540.